Chest wall and axillary lymph node FDG uptake associated with cancer vaccine therapy for lung cancer.
Cancer vaccines are now undergoing clinical investigations, and clinical trials of therapeutic cancer vaccines have been conducted mainly for advanced cancer patients. We experienced 2 cases of multifocal F-18 fluoro-2-deoxy-D-glucose uptake in the chest wall and axillary lymph nodes associated with personalized peptide vaccine therapy for recurrent lung cancer. In this article, we report fluoro-2-deoxy-D-glucose -positron emission tomography and positron emission tomography/computed tomography findings.
Kaneko
Koichiro
K
PET Imaging Center, Koga 21 Hospital, Miyanojin, Kurume City, Japan. kkaneko-kyu@umin.ac.jp
Yoshida
Tsuyoshi
T
Hiyama
Junichiro
J
Ono
Ken
K
Omagari
Junichi
J
D000368:Aged; D001365:Axilla / Q000000981:diagnostic imaging*; D019496:Cancer Vaccines / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D008297:Male; D049268:Positron-Emission Tomography; D012008:Recurrence; D055752:Small Cell Lung Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy; D035441:Thoracic Wall / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed
D019496:Cancer Vaccines; D019788:Fluorodeoxyglucose F18